Dividend funds have been a major focus of my Seeking Alpha coverage lately. With U.S. tech stocks again roaring to unheard-of highs, it has become prudent to look at cheaper sectors–sectors in which many dividend stocks are found.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for ...

When I was about 15 years old, I had my first girlfriend. And at the time, she was the first girl that had ever shown serious interest in me. I also thought maybe she'll be the only girl that will ever show interest in me.And so, I did everything in my power that I could to go ahead and keep her. I didn't have much money, but I would save up all my money, buy her roses, take her on dates, do everything I could, and she would tell me, "By goodness, Sanji, you're like the best thing that's ever happened to me ...

I would like to talk today on behalf of those who can see art in everything around them. It's not a gift we are born with, but rather a skill we develop through visual curiosity and observation. A puddle of milk spilled on the floor in a work environment maybe reveals just a mess that needs to be cleaned up or a composition of geometric forms that evoke suprematism.A pile of cardboard boxes maybe just part of studio assignment left for a classmate or maybe a deconstructed version of David reinterpreted and ...

Core Insights - Moderna (MRNA) received FDA approval for its COVID-19 vaccine, Spikevax, for children aged six months to 11 years at increased risk for the disease [1][6] - The vaccine was previously available under Emergency Use Authorization [1][6] - Following the announcement, Moderna's shares increased by 4.5% [1] Group 1: FDA Approval and Vaccine Availability - Spikevax is now fully approved for adults aged 65 and above, and individuals aged six months to 64 years at increased risk for severe COVID-19 [2] - The updated Spikevax will be available for eligible patients during the 2025-2026 vaccination season in the U.S. [2][6] Group 2: Stock Performance - Year-to-date, Moderna's shares have decreased by 17.5%, while the industry has seen a growth of 0.2% [3] Group 3: Competitive Landscape - Other COVID-19 vaccines include Pfizer (PFE)/BioNTech's (BNTX) Comirnaty and Novavax's (NVAX) Nuvaxovid, with Comirnaty also using mRNA technology [4] - Novavax's Nuvaxovid is the only non-mRNA vaccine in the U.S. and has received full approval for older adults and high-risk individuals aged 12-64 [7] Group 4: Company Ranking - Moderna currently holds a Zacks Rank of 3 (Hold) [8]

Group 1 - Bitcoin has distinguished itself from other risk assets over the past year, indicating its unique position in the market [1] - The Pragmatic Investor focuses on global macro, international equities, commodities, tech, and cryptocurrencies, aiming to guide investors through various market conditions [1] - The investment group emphasizes building robust and diversified portfolios to preserve and increase wealth over time [1]

Core Insights - Surf Air Mobility stock (NYSE:SRFM) has seen a significant increase, nearly doubling to approximately $7.60 per share, primarily driven by Palantir increasing its stake from 10% to almost 20% [1] - The company focuses on regional air travel, offering scheduled commercial air service, on-demand charter flights, and air cargo services, with plans to electrify short-haul regional air travel by 2027 [1] Financial Performance - Surf Air Mobility's revenue has grown by 31.2% over the last 12 months, increasing from $86 million to $112 million [3] - The company reported an Operating Income of -$44 million, resulting in an Operating Margin of -39.5% and an Operating Cash Flow of -$57 million, leading to an OCF margin of -51.0% [3] Balance Sheet Analysis - The company has $91 million in debt, leading to a Debt-to-Equity Ratio of about 30%, which is higher than the S&P 500 average of 19.4% [4] - Cash and cash equivalents are at $6.6 million, with a Cash-to-Assets Ratio of 6.3%, although this may have improved following a $27 million direct equity offering [4]

Core Viewpoint - NuCana plc plans to change the ratio of its American Depository Shares (ADSs) from 1 ADS representing 25 ordinary shares to 1 ADS representing 5,000 ordinary shares, effective around August 8, 2025, to support liquidity and regain compliance with Nasdaq's minimum bid price requirement [1][2]. Company Overview - NuCana is a clinical-stage biopharmaceutical company focused on improving cancer treatment outcomes through its ProTide technology, which aims to enhance the efficacy and safety of widely prescribed chemotherapy agents [4]. - The company's pipeline includes NUC-7738, a novel anti-cancer agent in Phase 2 studies, and NUC-3373, currently in a Phase 1b/2 modular study, both targeting advanced solid tumors [4]. ADS Ratio Change Details - The change in the ADS Ratio will effectively act as a one-for-two hundred reverse ADS split, with no impact on the proportional equity interest of ADS holders [2]. - Registered holders of certificated ADSs must surrender their existing ADSs for cancellation to receive new ADSs, while holders of uncertificated ADSs will have their ADSs automatically exchanged [2]. - No fractional new ADSs will be issued; instead, fractional entitlements will be aggregated and sold, with net cash proceeds distributed to ADS holders [2]. Expected Impact - The trading price of ADSs is expected to increase proportionally due to the change in the ADS Ratio, although the company cannot guarantee that the new trading price will be equal to or greater than the previous price [3].

In theory, trading crypto is among the fastest ways to make life-changing amounts of money. After all, some crypto traders have turned hundreds of dollars into millions of dollars in just a few days. In practice, however, most crypto traders will end up in the red, and some will lose all their money in a matter of minutes. This is because trading crypto is not like trading other assets. That's why today we're going to tell you everything you need to know about trading crypto starting from square one. By the ...

Company Overview - Will Somerindyke 十年前创立了 Regulus Global，一家军事供应链和物流公司 [1] - Regulus Global 成为 Somerindyke 新 defense tech 公司的首个客户 [1] Funding & Investment - Somerindyke 正在为其新的 defense tech 公司筹集数亿美元 (hundreds of millions) [1]

Core Viewpoint - Anonymous Intelligence Company Inc. is expanding its business strategy by developing SimpliiCrypto, an early-stage cryptocurrency project, under the leadership of CEO Denis Franks [1][2] Group 1: Business Strategy and Developments - The company is undertaking a non-brokered private placement of up to 5,000,000 units at a price of $0.15 per unit, aiming for gross proceeds of up to $750,000 [3] - The net proceeds from the offering will be used to broaden the technology business strategy, including cryptocurrency staking, mining, blockchain technology, and the development of decentralized applications [4] - A portion of the proceeds will be invested in a globally recognized cryptocurrency, with plans to stake the tokens quarterly to generate revenue [5] Group 2: Strategic Alliances - The company is seeking further strategic opportunities involving cryptocurrency-related assets through cash and equity arrangements [6] - ANON has entered into a strategic alliance with CannÖgen International, which focuses on health and wellness products, to secure appreciating assets that support shareholder value [7][8] - CannÖgen has issued ANON 444,444 warrants exercisable into common shares at a price of $0.1125 per share for two years, and ANON holds approximately a 1% ownership interest in CannÖgen [9] Group 3: Product Development - ANON is advancing the development of its proprietary Software Development Kit (SDK) and Virtual Private Network (VPN), which are being rebranded as Simplii Ai and Simplii VPN [10] - Under Mr. Franks' leadership, the company has significantly increased its market capitalization and improved its balance sheet by reducing over $350,000 in outstanding debt [11]